Comparing femoral nerve block and IV analgesia for hip fracture pain management
Comparison of the Efficiency of Femur Nerve Block and Analgesia Treatment in Hip Fracture Patients in Emergency Department
This study tests whether a femoral nerve block or IV pain medication works better for managing pain in older patients with hip fractures.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Enrollment | 119 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Marmara University Academic / other |
| Locations | 1 site (İstanbul, Pendik) |
| Trial ID | NCT06862154 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effectiveness of femoral nerve blocks versus intravenous analgesia in managing pain for patients with hip fractures. It aims to determine which method provides better pain control, enhances patient satisfaction, and supports quicker recovery. The study involves administering either fentanyl or a femoral nerve block to eligible patients and monitoring their pain levels and recovery outcomes. The trial is particularly focused on elderly patients who are at high risk for complications following hip fractures.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older with a confirmed proximal femur fracture who can provide informed consent.
Not a fit: Patients with hemodynamic instability, severe trauma, or known allergies to the study medications may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved pain management strategies for hip fracture patients, enhancing their recovery and quality of life.
How similar studies have performed: Previous studies have shown that peripheral nerve blocks can provide superior pain relief compared to systemic analgesia, indicating a promising approach in this area.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 years * Radiologically confirmed proximal femur fracture (femoral neck or intertrochanteric fracture) * Ability to provide informed consent or have a legal representative provide consent Exclusion Criteria: * Hemodynamic instability (SBP \<90 mmHg, HR \>120 bpm) * Severe trauma requiring immediate surgical intervention (e.g., multiple trauma, head injury) * Bleeding disorders or anticoagulation therapy (INR ≥2.5, platelet count \<50,000/mm³) * Known allergy to local anesthetics (bupivacaine) or opioids (fentanyl) * Pregnancy * Prior administration of local anesthetic blocks or systemic opioids before arrival * Periprosthetic fractures or previous surgery on the affected hip
Where this trial is running
İstanbul, Pendik
- Marmara University Pendik Training and Research Hospital — İstanbul, Pendik, Turkey (Recruiting)
Study contacts
- Study coordinator: Sinan Karacabey, Assoc. Prof.
- Email: karacabeysinan@gmail.com
- Phone: +905069138766
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.